Privi Speciality Chemicals Limited has informed the Exchange regarding Board meeting held on August 01, 2025 for approval of Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2025.
PRIVISCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.9 pts less than Nifty Microcap 250 and 1.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Privi Speciality Chemicals reported its Q1 FY26 results on August 1, 2025. Standalone revenue from operations grew to Rs. 56,635.59 lakhs, up about 28% from Rs. 44,116.43 lakhs in Q1 FY25. Consolidated revenue rose roughly 20% to Rs. 55,881.24 lakhs from Rs. 46,397.56 lakhs a year ago. Despite strong top-line growth, standalone net profit was nearly flat at Rs. 6,563.27 lakhs (vs Rs. 6,612.29 lakhs), and consolidated net profit dipped to Rs. 6,193.07 lakhs from Rs. 6,357.38 lakhs, indicating margin pressure from higher input and operating costs. Standalone EPS stood at Rs. 17.58 versus Rs. 16.93, while consolidated EPS slipped to Rs. 15.85 from Rs. 17.03. Statutory auditor BSR & Co. LLP issued an unmodified (clean) limited review report on both sets of results.
Strong revenue growth is a positive, but flat-to-declining profits signal cost-side challenges that may cap near-term upside. Clean auditor report and single-segment focus reduce governance concerns; investors will watch whether margins recover in upcoming quarters.